HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial

BACKGROUND: Characterizing viral response to lopinavir/ritonavir (LPV/r) monotherapy as second-line treatment may guide recommendations for resource-limited settings (RLS). METHODS: We conducted a 48-week prospective, single-arm study of LPV/r monotherapy in patients failing first-line therapy in Ni...

Descripción completa

Detalles Bibliográficos
Autores principales: Claassen, Cassidy W., Keckich, David, Nwizu, Chidi, Abimiku, Alash’le, Salami, Donald, Obiefune, Michael, Gilliam, Bruce L., Amoroso, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748552/
https://www.ncbi.nlm.nih.gov/pubmed/30798695
http://dx.doi.org/10.1177/2325958218823209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748552/
https://www.ncbi.nlm.nih.gov/pubmed/30798695
http://dx.doi.org/10.1177/2325958218823209

Ejemplares similares